Submitted by Anonymous (not verified) on 26 November 2025 - 13:45
Human medicines European public assessment report (EPAR): mResvia, Respiratory syncytial virus mRNA vaccine (nucleoside modified), Date of authorisation: 22/08/2024, Revision: 8, Status: Authorised
Source: